Skip to main content
OpenTrials

Clinical trial condition

Molybdenum Cofactor Deficiency, Complementation Group A

Explore clinical trials studying Molybdenum Cofactor Deficiency, Complementation Group A. Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Molybdenum Cofactor Deficiency, Complementation Group A trial results

Completed

Safety & Efficacy Study of ORGN001 (Formerly ALXN1101) in Pediatric Patients With MoCD Type A Currently Treated With rcPMP

NCT02047461

Conditions
Molybdenum Cofactor Deficiency, Complementation Group A, Molybdenum Cofactor Deficiency, Type A, Molybdenum cofactor deficiency
Locations
  • Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States
  • Monash Medical Centre Melbourne, Australia
  • Beatrix Children's Hospital Groningen, Netherlands
  • Unité des maladies métaboliques Tunis, Tunisia
View Trial Details
Completed

Study of ORGN001 (Formerly ALXN1101) in Neonates, Infants and Children With Molybdenum Cofactor Deficiency (MOCD) Type A

NCT02629393

Conditions
Molybdenum Cofactor Deficiency, Complementation Group A, Molybdenum Cofactor Deficiency, Type A, Molybdenum cofactor deficiency
Locations
  • Children's Hosptial of Michigan Detroit, Michigan, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States
  • HaEmek Medical Center Afula, Israel
View Trial Details
Active, Not Recruiting

Early Check: Expanded Screening in Newborns

NCT03655223

Conditions
17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations
  • RTI International Research Triangle Park, North Carolina, United States
View Trial Details

Related conditions